These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34774543)

  • 1. Out-of-pocket payments for part d covered medications by medicare fee-for-service beneficiaries with heart failure with reduced ejection fraction.
    Fendrick AM; Djatche L; Pulungan Z; Teigland C; Yang M; Lautsch D; Hilkert R; Mentz R
    Am Heart J; 2022 Apr; 246():74-81. PubMed ID: 34774543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality outcomes, healthcare resource utilization and costs in Medicare patients with chronic heart failure with reduced ejection fraction with and without a worsening event.
    Mentz RJ; Pulungan Z; Kim S; Yang M; Teigland C; Hilkert R; Djatche LM
    J Med Econ; 2021; 24(1):698-705. PubMed ID: 33900874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication Trajectory and Treatment Patterns in Medicare Patients With Heart Failure and Reduced Ejection Fraction.
    Mentz RJ; Lautsch D; Pulungan Z; Kim S; Hilkert R; Teigland C; Yang M; Djatche L
    J Card Fail; 2022 Aug; 28(8):1349-1354. PubMed ID: 34930657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Economic Burden of Chronic Heart Failure and Reduced Ejection Fraction Following a Worsening Heart Failure Event.
    Butler J; Djatche LM; Sawhney B; Chakladar S; Yang L; Brady JE; Yang M
    Adv Ther; 2020 Sep; 37(9):4015-4032. PubMed ID: 32761552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment patterns and clinical outcomes among patients <65 years with a worsening heart failure event.
    Butler J; Yang M; Sawhney B; Chakladar S; Yang L; Djatche LM
    Eur J Heart Fail; 2021 Aug; 23(8):1334-1342. PubMed ID: 34053163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription drug spending and hospital use among Medicare beneficiaries with heart failure.
    McGee BT; Higgins MK; Phillips V; Butler J
    Res Social Adm Pharm; 2020 Oct; 16(10):1452-1458. PubMed ID: 31953113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare Coverage and Out-of-Pocket Costs of Quadruple Drug Therapy for Heart Failure.
    Faridi KF; Dayoub EJ; Ross JS; Dhruva SS; Ahmad T; Desai NR
    J Am Coll Cardiol; 2022 Jun; 79(25):2516-2525. PubMed ID: 35738713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal pro-B-type natriuretic peptide testing patterns in patients with heart failure with reduced ejection fraction.
    Januzzi JL; Tan X; Yang L; Brady JE; Yang M; Banka P; Lautsch D
    ESC Heart Fail; 2022 Feb; 9(1):87-99. PubMed ID: 34918487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Inflation Reduction Act and Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Disease.
    Kazi DS; DeJong C; Chen R; Wadhera RK; Tseng CW
    J Am Coll Cardiol; 2023 May; 81(21):2103-2111. PubMed ID: 37225364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiologic Characterization of Heart Failure with Reduced or Preserved Ejection Fraction Populations Identified Using Medicare Claims.
    Desai RJ; Mahesri M; Chin K; Levin R; Lahoz R; Studer R; Vaduganathan M; Patorno E
    Am J Med; 2021 Apr; 134(4):e241-e251. PubMed ID: 33127370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary outpatient management of patients with worsening heart failure with reduced ejection fraction: Clinical outcome results from the CHART-HF study.
    Gaggin HK; Greene SJ; Zhou M; Lautsch D; Bash LD; Djatche L; Song Y; Signorovitch J; Stevenson AS; Blaustein RO; Butler J
    Int J Cardiol Cardiovasc Risk Prev; 2024 Jun; 21():200278. PubMed ID: 38766664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sociodemographic and spending characteristics of Medicare beneficiaries taking prescription drugs subject to price negotiations.
    Odouard IC; Anderson GF; Alexander GC; Ballreich J
    J Manag Care Spec Pharm; 2024 Mar; 30(3):269-278. PubMed ID: 38140901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-centered Outcomes in HFrEF Following a Worsening Heart Failure Event: A Survey Analysis.
    Dunbar SB; Tan X; Lautsch D; Yang M; Ricker B; Maculaitis MC; Nagle T; Clark LT; Hilkert R; Brady JE; Spertus JA
    J Card Fail; 2021 Aug; 27(8):877-887. PubMed ID: 34364664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing patient OOP spending for specialty drugs in Medicare Part D and employer-sponsored insurance.
    Parasrampuria S; Sen AP; Anderson GF
    Am J Manag Care; 2020 Sep; 26(9):388-394. PubMed ID: 32930551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment patterns of patients with worsening heart failure with reduced ejection fraction.
    Greene SJ; Gaggin HK; Zhou M; Bash LD; Lautsch D; Djatche L; Song Y; Signorovitch J; Stevenson AS; Blaustein RO; Butler J
    ESC Heart Fail; 2024 Aug; 11(4):1932-1946. PubMed ID: 38639469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Out-of-Pocket Costs for Long-Acting Injectable and Oral Antipsychotics Among Medicare Patients With Schizophrenia.
    Doshi JA; Li P; Geng Z; Seo S; Patel C; Benson C
    Psychiatr Serv; 2024 Apr; 75(4):333-341. PubMed ID: 37960866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of an out-of-pocket maximum in Medicare Part D.
    Parasrampuria S; Anderson GF
    Am J Manag Care; 2022 Feb; 28(2):e55-e62. PubMed ID: 35139297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inpatient Utilization and Costs for Medicare Fee-for-Service Beneficiaries with Heart Failure.
    Fitch K; Pelizzari PM; Pyenson B
    Am Health Drug Benefits; 2016 Apr; 9(2):96-104. PubMed ID: 27182428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary outpatient management of patients with worsening heart failure with reduced ejection fraction: Rationale and design of the CHART-HF study.
    Greene SJ; Lautsch D; Gaggin HK; Djatche LM; Zhou M; Song Y; Signorovitch J; Stevenson AS; Blaustein RO; Butler J
    Am Heart J; 2022 Sep; 251():127-136. PubMed ID: 35640728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
    Patel UD; Davis MM
    J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.